Top

Published in:

01-10-2019 | Type 1 Diabetes | Review

Early-life factors contributing to type 1 diabetes

Authors: Maria E. Craig, Ki Wook Kim, Sonia R. Isaacs, Megan A. Penno, Emma E. Hamilton-Williams, Jennifer J. Couper, William D. Rawlinson

Published in: Diabetologia | Issue 10/2019

Abstract

The incidence of type 1 diabetes has increased since the mid-twentieth century at a rate that is too rapid to be attributed to genetic predisposition alone. While the disease can occur at any age, mounting evidence from longitudinal cohort studies of at-risk children indicate that type 1 diabetes associated autoantibodies can be present from the first year of life, and that those who develop type 1 diabetes at a young age have a more aggressive form of the disease. This corroborates the hypothesis that environmental exposures in early life contribute to type 1 diabetes risk, whether related to maternal influences on the fetus during pregnancy, neonatal factors or later effects during infancy and early childhood. Studies to date show a range of environmental triggers acting at different time points, suggesting a multifactorial model of genetic and environmental factors in the pathogenesis of type 1 diabetes, which integrally involves a dialogue between the immune system and pancreatic beta cells. For example, breastfeeding may have a weak protective effect on type 1 diabetes risk, while use of an extensively hydrolysed formula does not. Additionally, exposure to being overweight pre-conception, both in utero and postnatally, is associated with increased risk of type 1 diabetes. Epidemiological, clinical and pathological studies in humans support a role for viral infections, particularly enteroviruses, in type 1 diabetes, but definitive proof is lacking. The role of the early microbiome and its perturbations in islet autoimmunity and type 1 diabetes is the subject of investigation in ongoing cohort studies. Understanding the interactions between environmental exposures and the human genome and metagenome, particularly across ethnically diverse populations, will be critical for the development of future strategies for primary prevention of type 1 diabetes.

Available only for authorised users

Hermann R, Knip M, Veijola R et al (2003) Temporal changes in the frequencies of HLA genotypes in patients with type 1 diabetes--indication of an increased environmental pressure? Diabetologia 46(3):420–425. https://doi.org/10.1007/s00125-003-1045-4 CrossRefPubMed

Gillespie KM, Bain SC, Barnett AH et al (2004) The rising incidence of childhood type 1 diabetes and reduced contribution of high-risk HLA haplotypes. Lancet 364(9446):1699–1700. https://doi.org/10.1016/S0140-6736(04)17357-1 CrossRefPubMed

Fourlanos S, Varney MD, Tait BD et al (2008) The rising incidence of type 1 diabetes is accounted for by cases with lower-risk human leukocyte antigen genotypes. Diabetes Care 31(8):1546–1549. https://doi.org/10.2337/dc08-0239 CrossRefPubMedPubMedCentral

Couper JJ, Beresford S, Hirte C et al (2009) Weight gain in early life predicts risk of islet autoimmunity in children with a first-degree relative with type 1 diabetes. Diabetes Care 32(1):94–99. https://doi.org/10.2337/dc08-0821 CrossRefPubMedPubMedCentral

Honeyman MC, Coulson BS, Stone NL et al (2000) Association between rotavirus infection and pancreatic islet autoimmunity in children at risk of developing type 1 diabetes. Diabetes 49(8):1319–1324. https://doi.org/10.2337/diabetes.49.8.1319 CrossRefPubMed

Ziegler AG, Schmid S, Huber D, Hummel M, Bonifacio E (2003) Early infant feeding and risk of developing type 1 diabetes-associated autoantibodies. JAMA 290(13):1721–1728. https://doi.org/10.1001/jama.290.13.1721 CrossRefPubMed

Hummel S, Pfluger M, Hummel M, Bonifacio E, Ziegler AG (2011) Primary dietary intervention study to reduce the risk of islet autoimmunity in children at increased risk for type 1 diabetes: the BABYDIET study. Diabetes Care 34(6):1301–1305. https://doi.org/10.2337/dc10-2456 CrossRefPubMedPubMedCentral

Ferreira RC, Guo H, Coulson RM et al (2014) A type I interferon transcriptional signature precedes autoimmunity in children genetically at risk for type 1 diabetes. Diabetes 63(7):2538–2550. https://doi.org/10.2337/db13-1777 CrossRefPubMedPubMedCentral

Hippich M, Oleynik A, Jain K et al (2018) Searching peripheral blood mononuclear cells of children with viral respiratory tract infections preceding islet autoimmunity for viruses by high-throughput sequencing. Acta Diabetol 55(8):881–884. https://doi.org/10.1007/s00592-018-1138-7 CrossRefPubMed

10.

Lamb MM, Miller M, Seifert JA et al (2015) The effect of childhood cow’s milk intake and HLA-DR genotype on risk of islet autoimmunity and type 1 diabetes: the Diabetes Autoimmunity Study in the Young. Pediatr Diabetes 16(1):31–38. https://doi.org/10.1111/pedi.12115 CrossRefPubMed

11.

Harrison LC, Honeyman MC (1999) Cow’s milk and type 1 diabetes: the real debate is about mucosal immune function. Diabetes 48(8):1501–1507. https://doi.org/10.2337/diabetes.48.8.1501 CrossRefPubMed

12.

Zhao G, Vatanen T, Droit L et al (2017) Intestinal virome changes precede autoimmunity in type I diabetes-susceptible children. Proc Natl Acad Sci U S A 114(30):E6166–E6175. https://doi.org/10.1073/pnas.1706359114 CrossRefPubMedPubMedCentral

13.

Vatanen T, Plichta DR, Somani J et al (2019) Genomic variation and strain-specific functional adaptation in the human gut microbiome during early life. Nat Microbiol 4(3):470–479. https://doi.org/10.1038/s41564-018-0321-5 CrossRefPubMed

14.

Virtanen SM, Rasanen L, Ylonen K et al (1993) Early introduction of dairy products associated with increased risk of IDDM in Finnish children. The Childhood in Diabetes in Finland Study Group. Diabetes 42(12):1786–1790. https://doi.org/10.2337/diab.42.12.1786 CrossRefPubMed

15.

Lempainen J, Tauriainen S, Vaarala O et al (2012) Interaction of enterovirus infection and cow’s milk-based formula nutrition in type 1 diabetes-associated autoimmunity. Diabetes Metab Res Rev 28(2):177–185. https://doi.org/10.1002/dmrr.1294 CrossRefPubMed

16.

Virtanen SM, Kenward MG, Erkkola M et al (2006) Age at introduction of new foods and advanced beta cell autoimmunity in young children with HLA-conferred susceptibility to type 1 diabetes. Diabetologia 49(7):1512–1521. https://doi.org/10.1007/s00125-006-0236-1 CrossRefPubMed

17.

Virtanen SM, Takkinen HM, Nevalainen J et al (2011) Early introduction of root vegetables in infancy associated with advanced ss-cell autoimmunity in young children with human leukocyte antigen-conferred susceptibility to type 1 diabetes. Diabet Med 28(8):965–971. https://doi.org/10.1111/j.1464-5491.2011.03294.x CrossRefPubMed

18.

Kramna L, Kolarova K, Oikarinen S et al (2015) Gut virome sequencing in children with early islet autoimmunity. Diabetes Care 38(5):930–933. https://doi.org/10.2337/dc14-2490 CrossRefPubMed

19.

Thorsen SU, Marild K, Olsen SF et al (2018) Lack of association between maternal or neonatal vitamin D status and risk of childhood type 1 diabetes: a Scandinavian case-cohort study. Am J Epidemiol 187(6):1174–1181. https://doi.org/10.1093/aje/kwx361 CrossRefPubMed

20.

Magnus MC, Olsen SF, Granstrom C et al (2018) Paternal and maternal obesity but not gestational weight gain is associated with type 1 diabetes. Int J Epidemiol 47(2):417–426. https://doi.org/10.1093/ije/dyx266 CrossRefPubMedPubMedCentral

21.

Penno MA, Couper JJ, Craig ME et al (2013) Environmental determinants of islet autoimmunity (ENDIA): a pregnancy to early life cohort study in children at-risk of type 1 diabetes. BMC Pediatr 13(1):124. https://doi.org/10.1186/1471-2431-13-124 CrossRefPubMedPubMedCentral

22.

Wook Kim K, Allen DW, Briese T et al (2019) Distinct gut virome profile of pregnant women with type 1 diabetes in the ENDIA study. Open Forum Infect Dis 6(2):ofz025. https://doi.org/10.1093/ofid/ofz025 CrossRefPubMedPubMedCentral

23.

Beyerlein A, Donnachie E, Jergens S, Ziegler AG (2016) Infections in early life and development of type 1 diabetes. JAMA 315(17):1899–1901. https://doi.org/10.1001/jama.2016.2181 CrossRefPubMed

24.

Rasmussen T, Witso E, Tapia G, Stene LC, Ronningen KS (2011) Self-reported lower respiratory tract infections and development of islet autoimmunity in children with the type 1 diabetes high-risk HLA genotype: the MIDIA study. Diabetes Metab Res Rev 27(8):834–837. https://doi.org/10.1002/dmrr.1258 CrossRefPubMed

25.

Lin HC, Wang CH, Tsai FJ et al (2015) Enterovirus infection is associated with an increased risk of childhood type 1 diabetes in Taiwan: a nationwide population-based cohort study. Diabetologia 58(1):79–86. https://doi.org/10.1007/s00125-014-3400-z CrossRefPubMed

26.

Ponsonby AL, Pezic A, Cochrane J et al (2011) Infant anthropometry, early life infection, and subsequent risk of type 1 diabetes mellitus: a prospective birth cohort study. Pediatr Diabetes 12(4 Pt 1):313–321. https://doi.org/10.1111/j.1399-5448.2010.00693.x CrossRefPubMed

27.

Hippich M, Beyerlein A, Hagopian WA et al (2019) Genetic contribution to the divergence in type 1 diabetes risk between children from the general population and children from affected families. Diabetes 68(4):847–857. https://doi.org/10.2337/db18-0882 CrossRefPubMed

28.

Uusitalo U, Lee HS, Andren Aronsson C et al (2018) Early infant diet and islet autoimmunity in the TEDDY study. Diabetes Care 41(3):522–530. https://doi.org/10.2337/dc17-1983 CrossRefPubMedPubMedCentral

29.

Lonnrot M, Lynch KF, Elding Larsson H et al (2017) Respiratory infections are temporally associated with initiation of type 1 diabetes autoimmunity: the TEDDY study. Diabetologia 60(10):1931–1940. https://doi.org/10.1007/s00125-017-4365-5 CrossRefPubMedPubMedCentral

30.

Lynch KF, Lee HS, Torn C et al (2018) Gestational respiratory infections interacting with offspring HLA and CTLA-4 modifies incident beta-cell autoantibodies. J Autoimmun 86:93–103. https://doi.org/10.1016/j.jaut.2017.09.005 CrossRefPubMed

31.

Lee HS, Briese T, Winkler C et al (2013) Next-generation sequencing for viruses in children with rapid-onset type 1 diabetes. Diabetologia 56(8):1705–1711. https://doi.org/10.1007/s00125-013-2924-y CrossRefPubMedPubMedCentral

32.

Stewart CJ, Ajami NJ, O’Brien JL et al (2018) Temporal development of the gut microbiome in early childhood from the TEDDY study. Nature 562(7728):583–588. https://doi.org/10.1038/s41586-018-0617-x CrossRefPubMedPubMedCentral

33.

Vatanen T, Franzosa EA, Schwager R et al (2018) The human gut microbiome in early-onset type 1 diabetes from the TEDDY study. Nature 562(7728):589–594. https://doi.org/10.1038/s41586-018-0620-2 CrossRefPubMedPubMedCentral

34.

Knip M, Akerblom HK, Becker D et al (2014) Hydrolyzed infant formula and early β-cell autoimmunity: a randomized clinical trial. JAMA 311(22):2279–2287. https://doi.org/10.1001/jama.2014.5610 CrossRefPubMedPubMedCentral

35.

Writing Group for the TRIGR Study Group (2018) Effect of hydrolyzed infant formula vs conventional formula on risk of type 1 diabetes: the TRIGR randomized clinical trial. JAMA 319(1):38–48. https://doi.org/10.1001/jama.2017.19826 CrossRefPubMedCentral

36.

Kim KW, Horton JL, Pang CNI et al (2019) Higher abundance of enterovirus A species in the gut of children with islet autoimmunity. Sci Rep 9(1):1749. https://doi.org/10.1038/s41598-018-38368-8 CrossRefPubMedPubMedCentral

37.

Noble JA, Valdes AM (2011) Genetics of the HLA region in the prediction of type 1 diabetes. Curr Diab Rep 11(6):533–542. https://doi.org/10.1007/s11892-011-0223-x CrossRefPubMedPubMedCentral

38.

Rich SS, Akolkar B, Concannon P et al (2009) Overview of the Type I Diabetes Genetics Consortium. Genes Immun 10(Suppl 1):S1–S4. https://doi.org/10.1038/gene.2009.84 CrossRefPubMedPubMedCentral

39.

Bonifacio E, Beyerlein A, Hippich M et al (2018) Genetic scores to stratify risk of developing multiple islet autoantibodies and type 1 diabetes: a prospective study in children. PLoS Med 15(4):e1002548. https://doi.org/10.1371/journal.pmed.1002548 CrossRefPubMedPubMedCentral

40.

Perry DJ, Wasserfall CH, Oram RA et al (2018) Application of a genetic risk score to racially diverse type 1 diabetes populations demonstrates the need for diversity in risk-modeling. Sci Rep 8(1):4529. https://doi.org/10.1038/s41598-018-22574-5 CrossRefPubMedPubMedCentral

41.

Sharp SA, Rich SS, Wood AR et al (2019) Development and standardization of an improved type 1 diabetes genetic risk score for use in newborn screening and incident diagnosis. Diabetes Care 42(2):200–207. https://doi.org/10.2337/dc18-1785 CrossRefPubMed

42.

Hommel A, Haupt F, Delivani P et al (2018) Screening for type 1 diabetes risk in newborns: the Freder1k Pilot Study in Saxony. Horm Metab Res 50(1):44–49. https://doi.org/10.1055/s-0043-120921 CrossRefPubMed

43.

Zhao Z, Miao D, Michels A et al (2016) A multiplex assay combining insulin, GAD, IA-2 and transglutaminase autoantibodies to facilitate screening for pre-type 1 diabetes and celiac disease. J Immunol Methods 430:28–32. https://doi.org/10.1016/j.jim.2016.01.011 CrossRefPubMedPubMedCentral

44.

Antvorskov JC, Halldorsson TI, Josefsen K et al (2018) Association between maternal gluten intake and type 1 diabetes in offspring: national prospective cohort study in Denmark. BMJ 362:k3547. https://doi.org/10.1136/bmj.k3547

45.

Fronczak CM, Baron AE, Chase HP et al (2003) In utero dietary exposures and risk of islet autoimmunity in children. Diabetes Care 26(12):3237–3242. https://doi.org/10.2337/diacare.26.12.3237 CrossRefPubMed

46.

Tapia G, Marild K, Dahl SR et al (2019) Maternal and newborn vitamin d-binding protein, vitamin D levels, vitamin D receptor genotype, and childhood type 1 diabetes. Diabetes Care 42(4):553–559. https://doi.org/10.2337/dc18-2176 CrossRefPubMed

47.

Li X, Atkinson MA (2015) The role for gut permeability in the pathogenesis of type 1 diabetes – a solid or leaky concept? Pediatr Diabetes 16(7):485–492. https://doi.org/10.1111/pedi.12305 CrossRefPubMedPubMedCentral

48.

Cardwell CR, Stene LC, Ludvigsson J et al (2012) Breast-feeding and childhood-onset type 1 diabetes: a pooled analysis of individual participant data from 43 observational studies. Diabetes Care 35(11):2215–2225. https://doi.org/10.2337/dc12-0438 CrossRefPubMedPubMedCentral

49.

Stordal K, Lundeby KM, Brantsaeter AL et al (2017) Breast-feeding and infant hospitalization for infections: large cohort and sibling analysis. J Pediatr Gastroenterol Nutr 65(2):225–231. https://doi.org/10.1097/MPG.0000000000001539 CrossRefPubMedPubMedCentral

50.

Sterne JA, Gavaghan D, Egger M (2000) Publication and related bias in meta-analysis: power of statistical tests and prevalence in the literature. J Clin Epidemiol 53(11):1119–1129. https://doi.org/10.1016/S0895-4356(00)00242-0 CrossRefPubMed

51.

Cardwell CR, Stene LC, Joner G et al (2010) Birthweight and the risk of childhood-onset type 1 diabetes: a meta-analysis of observational studies using individual patient data. Diabetologia 53(4):641–651. https://doi.org/10.1007/s00125-009-1648-5 CrossRefPubMed

52.

Fourlanos S (2005) Insulin resistance in children and adolescents with type 1 diabetes mellitus: relation to obesity. Pediatr Diabetes 6(1):3–4. https://doi.org/10.1111/j.1399-543X.2005.00094.x CrossRefPubMed

53.

Islam ST, Srinivasan S, Craig ME (2014) Environmental determinants of type 1 diabetes: a role for overweight and insulin resistance. J Paediatr Child Health 50(11):874–879. https://doi.org/10.1111/jpc.12616 CrossRefPubMed

54.

Gundersen E (1927) Is diabetes of infectious origin? J Infect Dis 41(3):197–202. https://doi.org/10.1093/infdis/41.3.197 CrossRef

55.

Allen DW, Kim K, Rawlinson WD, Craig ME (2018) Maternal virus infections in pregnancy and type 1 diabetes in their offspring: systematic review and meta-analysis of observational studies. Rev Med Virol 28(3):e1974. https://doi.org/10.1002/rmv.1974 CrossRefPubMed

56.

Sykes L, MacIntyre DA, Yap XJ, Teoh TG, Bennett PR (2012) The Th1:Th2 dichotomy of pregnancy and preterm labour. Mediat Inflamm 2012:967629–967612. https://doi.org/10.1155/2012/967629 CrossRef

57.

Scott GM, Chow SS, Craig ME et al (2012) Cytomegalovirus infection during pregnancy with maternofetal transmission induces a proinflammatory cytokine bias in placenta and amniotic fluid. J Infect Dis 205(8):1305–1310. https://doi.org/10.1093/infdis/jis186 CrossRefPubMed

58.

Takasu N, Ikema T, Komiya I, Mimura G (2005) Forty-year observation of 280 Japanese patients with congenital rubella syndrome. Diabetes Care 28(9):2331–2332. https://doi.org/10.2337/diacare.28.9.2331 CrossRefPubMed

59.

Op de Beeck A, Eizirik DL (2016) Viral infections in type 1 diabetes mellitus — why the beta cells? Nat Rev Endocrinol 12(5):263–273. https://doi.org/10.1038/nrendo.2016.30 CrossRefPubMedCentral

60.

Nejentsev S, Walker N, Riches D, Egholm M, Todd JA (2009) Rare variants of IFIH1, a gene implicated in antiviral responses, protect against type 1 diabetes. Science 324(5925):387–389. https://doi.org/10.1126/science.1167728 CrossRefPubMedPubMedCentral

61.

Clausen TD, Bergholt T, Bouaziz O et al (2016) Broad-spectrum antibiotic treatment and subsequent childhood type 1 diabetes: a nationwide Danish cohort study. PLoS One 11(8):e0161654. https://doi.org/10.1371/journal.pone.0161654 CrossRefPubMedPubMedCentral

62.

Morgan NG, Richardson SJ (2018) Fifty years of pancreatic islet pathology in human type 1 diabetes: insights gained and progress made. Diabetologia 61(12):2499–2506. https://doi.org/10.1007/s00125-018-4731-y CrossRefPubMedPubMedCentral

63.

Dunne JL, Richardson SJ, Atkinson MA et al (2019) Rationale for enteroviral vaccination and antiviral therapies in human type 1 diabetes. Diabetologia 62(5):744–753. https://doi.org/10.1007/s00125-019-4811-7 CrossRefPubMedPubMedCentral

64.

Pak CY, Eun HM, McArthur RG, Yoon JW (1988) Association of cytomegalovirus infection with autoimmune type 1 diabetes. Lancet 2(8601):1–4. https://doi.org/10.1016/s0140-6736(88)92941-8 CrossRefPubMed

65.

Bian X, Wallstrom G, Davis A et al (2016) Immunoproteomic profiling of antiviral antibodies in new-onset type 1 diabetes using protein arrays. Diabetes 65(1):285–296. https://doi.org/10.2337/db15-0179 CrossRefPubMed

66.

Ramondetti F, Sacco S, Comelli M et al (2012) Type 1 diabetes and measles, mumps and rubella childhood infections within the Italian Insulin-dependent Diabetes Registry. Diabet Med 29(6):761–766. https://doi.org/10.1111/j.1464-5491.2011.03529.x CrossRefPubMed

67.

Kolehmainen P, Koskiniemi M, Oikarinen S et al (2013) Human parechovirus and the risk of type 1 diabetes. J Med Virol 85(9):1619–1623. https://doi.org/10.1002/jmv.23659 CrossRefPubMed

68.

Yeung G, Rawlinson WD, Craig ME (2011) Enterovirus infection and type 1 diabetes mellitus: systematic review and meta-analysis of observational molecular studies. BMJ 342:d35. https://doi.org/10.1136/bmj.d35

69.

Lonnrot M, Salminen K, Knip M et al (2000) Enterovirus RNA in serum is a risk factor for beta-cell autoimmunity and clinical type 1 diabetes: a prospective study. Childhood Diabetes in Finland (DiMe) Study Group. J Med Virol 61(2):214–220. https://doi.org/10.1002/(SICI)1096-9071(200006)61:2<214::AID-JMV7>3.0.CO;2-9 CrossRefPubMed

70.

Laitinen OH, Honkanen H, Pakkanen O et al (2014) Coxsackievirus B1 is associated with induction of beta-cell autoimmunity that portends type 1 diabetes. Diabetes 63(2):446–455. https://doi.org/10.2337/db13-0619 CrossRefPubMed

71.

Oikarinen S, Martiskainen M, Tauriainen S et al (2011) Enterovirus RNA in blood is linked to the development of type 1 diabetes. Diabetes 60(1):2769–2279. https://doi.org/10.2337/db10-0186 CrossRef

72.

Perrett KP, Jachno K, Nolan TM, Harrison LC (2019) Association of rotavirus vaccination with the incidence of type 1 diabetes in children. JAMA Pediatr 173(3):280–282. https://doi.org/10.1001/jamapediatrics.2018.4578 CrossRefPubMed

73.

Rogers MAM, Basu T, Kim C (2019) Lower incidence rate of type 1 diabetes after receipt of the rotavirus vaccine in the United States, 2001-2017. Sci Rep 9(1):7727. https://doi.org/10.1038/s41598-019-44193-4 CrossRefPubMedPubMedCentral

74.

Briese T, Kapoor A, Mishra N et al (2015) Virome capture sequencing enables sensitive viral diagnosis and comprehensive virome analysis. MBio 6(5):e01491–e01415. https://doi.org/10.1128/mBio.01491-15 CrossRefPubMedPubMedCentral

75.

Kostic AD, Gevers D, Siljander H et al (2015) The dynamics of the human infant gut microbiome in development and in progression toward type 1 diabetes. Cell Host Microbe 17(2):260–273. https://doi.org/10.1016/j.chom.2015.01.001 CrossRefPubMedPubMedCentral

76.

Koren O, Goodrich JK, Cullender TC et al (2012) Host remodeling of the gut microbiome and metabolic changes during pregnancy. Cell 150(3):470–480. https://doi.org/10.1016/j.cell.2012.07.008 CrossRefPubMedPubMedCentral

77.

DiGiulio DB, Callahan BJ, McMurdie PJ et al (2015) Temporal and spatial variation of the human microbiota during pregnancy. Proc Natl Acad Sci U S A 112(35):11060–11065. https://doi.org/10.1073/pnas.1502875112 CrossRefPubMedPubMedCentral

78.

Haupt-Jorgensen M, Morgen CS, Jess T et al (2018) Maternal antibiotic use during pregnancy and type 1 diabetes in children—a national prospective cohort study. Diabetes Care 41(12):e155–e157. https://doi.org/10.2337/dc18-1764 CrossRefPubMed

79.

Arpaia N, Campbell C, Fan X et al (2013) Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation. Nature 504(7480):451–455. https://doi.org/10.1038/nature12726 CrossRefPubMedPubMedCentral

80.

Gavin PG, Mullaney JA, Loo D et al (2018) Intestinal metaproteomics reveals host-microbiota interactions in subjects at risk for type 1 diabetes. Diabetes Care 41(10):2178–2186. https://doi.org/10.2337/dc18-0777 CrossRefPubMedPubMedCentral

81.

Marino E, Richards JL, McLeod KH et al (2017) Gut microbial metabolites limit the frequency of autoimmune T cells and protect against type 1 diabetes. Nat Immunol 18(5):552–562. https://doi.org/10.1038/ni.3713 CrossRefPubMed

82.

de Goffau MC, Fuentes S, van den Bogert B et al (2014) Aberrant gut microbiota composition at the onset of type 1 diabetes in young children. Diabetologia 57(8):1569–1577. https://doi.org/10.1007/s00125-014-3274-0 CrossRefPubMed

83.

Eizirik DL, Miani M, Cardozo AK (2013) Signalling danger: endoplasmic reticulum stress and the unfolded protein response in pancreatic islet inflammation. Diabetologia 56(2):234–241. https://doi.org/10.1007/s00125-012-2762-3 CrossRefPubMed

84.

Thomaidou S, Zaldumbide A, Roep BO (2018) Islet stress, degradation and autoimmunity. Diabetes Obes Metab 20(Suppl 2):88–94. https://doi.org/10.1111/dom.13387 CrossRefPubMedPubMedCentral

85.

Kracht MJ, van Lummel M, Nikolic T et al (2017) Autoimmunity against a defective ribosomal insulin gene product in type 1 diabetes. Nat Med 23(4):501–507. https://doi.org/10.1038/nm.4289 CrossRefPubMed

86.

Kaplan RM, Chambers DA, Glasgow RE (2014) Big data and large sample size: a cautionary note on the potential for bias. Clin Transl Sci 7(4):342–346. https://doi.org/10.1111/cts.12178 CrossRefPubMedPubMedCentral

87.

Mayer-Davis EJ, Kahkoska AR, Jefferies C et al (2018) ISPAD Clinical Practice Consensus Guidelines 2018: definition, epidemiology and classification of diabetes in children and adolescents. Pediatr Diabetes 19(Suppl 27):7–19. https://doi.org/10.1111/pedi.12773 CrossRefPubMed

Title: Early-life factors contributing to type 1 diabetes
Authors: Maria E. Craig
Ki Wook Kim
Sonia R. Isaacs
Megan A. Penno
Emma E. Hamilton-Williams
Jennifer J. Couper
William D. Rawlinson
Publication date: 01-10-2019
Publisher: Springer Berlin Heidelberg
Keyword: Type 1 Diabetes
Published in: Diabetologia / Issue 10/2019
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI: https://doi.org/10.1007/s00125-019-4942-x

ACC 2024 Congress Coverage

Heart Failure Video

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Early-life factors contributing to type 1 diabetes

Abstract

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 10/2019

Sex differences in the burden of type 2 diabetes and cardiovascular risk across the life course

Environmental neglect: endocrine disruptors as underappreciated but potentially modifiable diabetes risk factors

Paternal impact on the life course development of obesity and type 2 diabetes in the offspring

The role of GIP and pancreatic GLP-1 in the glucoregulatory effect of DPP-4 inhibition in mice

Canagliflozin and fracture risk in individuals with type 2 diabetes: results from the CANVAS Program

A life course perspective on diabetes: developmental origins and beyond

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page